# Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

> **NCT02192788** · NA · COMPLETED · sponsor: **Grupo de Investigación Clínica en Oncología Radioterapia** · enrollment: 68 (actual)

## Conditions studied

- Oligometastatic Prostate Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy for Oligometastases

## Key facts

- **NCT ID:** NCT02192788
- **Lead sponsor:** Grupo de Investigación Clínica en Oncología Radioterapia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192788, "Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02192788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*